All News

A new report requested by Rep. Henry Waxman finds that private insurers are not operating their Medicare Part D programs efficiently.

NCPA CEO Bruce Roberts urges members to get more involved in medication therapy management, e-prescribing, and lobbying legislators at annual convention.

Although the number of independent pharmacies has decreased from 2006, salary levels for pharmacists and technicians have increased.

WellPoint opens specialty pharmacy in airport

Dietary supplements confiscated by FDA

John Rector plans to step down from his position as general counsel for NCPA in 2008

FDA issues new warnings about Definity and Optison contrast agents

States look to expand Medicaid benefits and eligibility as the program enrollment and spending remain low.

Consumers Union, publisher of Consumer Reports, criticizes the Centers for Medicare & Medicaid Service's system for rating Medicare Part D prescription drug plans as meaningless.

The eye care community is disconcerted by Genentech's decision to restrict access to its cancer drug Avastin.

OIG report finds the Centers for Medicare & Medicaid Services was slow to respond to fraud allegations against prescription drug plans and lacked an antifraud strategy.

Three deaths determined to be result of colchicine toxicity

Maryland pharmacists urge House Majority Leader Hoyer to put patients first

Children are using more medications to treat gastrointestinal problems

The National Association of Boards of Pharmacy has reinstated the North American Pharmacist Licensure Exam at all the Prometric testing centers.

The Centers for Medicare & Medicaid Services has released an improved plan finder with details on 2008 Medicare Part D prescription drug plans.

Two Hispanic pharmacy chains combine under Navarro name

Several manufacturers withdraw over-the-counter cough and cold products

New metabolic warnings added to olanzapine product labels

First oxcarbazepine receives approval for seizure disorders

Robert J. Bolger has died

Battle over ESA coverage continues

Medi-Promotions to launch Medi-Scripts Plus prescription pad

FDA grants full approval of tipranavir.

U.S. payers to incorporate biogeneric agents into their formularies

2008 Medicare Part D premiums to rise 21%, according to study by Avalere Health.

CVS Caremark celebrates American Pharmacists Month

Mipomersen sodium is the new generic name for Isis Pharmaceuticals' anticholesterol drug ISIS 301012.